微软研究院
For the series finale, Peter Lee, Carey Goldberg, and Dr. Zak Kohane compare their predictions to insights from the series’ most recent guests, including experts on AI’s economic and societal impact, leaders in AI-driven medicine, and doctors in training.
Former Washington State Secretary of Health Dr. Umair Shah and Mayo Clinic CEO Dr. Gianrico Farrugia explore how healthcare leaders are approaching AI when it comes to public health, care delivery, the healthcare-research connection, and the patient experience.
Next-generation physicians Morgan Cheatham and Daniel Chen discuss how generative AI is transforming medical education, exploring how students and attending physicians integrate new tools while navigating questions on trust, training, and responsibility.
Daphne Koller, Noubar Afeyan, and Dr. Eric Topol, leaders in AI-driven medicine, discuss how AI is changing biomedical research and discovery, from accelerating drug target identification and biotech R&D to helping pursue the “holy grail” of a virtual cell.
Technologists Bill Gates and Sébastien Bubeck discuss the state of generative AI in medicine, how access to “medical intelligence” might help empower people across healthcare, and how AI’s accelerating improvements are likely to affect both delivery and discovery.
Ethan Mollick and Azeem Azhar, thought leaders at the forefront of AI’s influence on work, education, and society, discuss the impact of AI at the individual level and what that means for the healthcare workforce and the organizations and systems in medicine.
Peter Lee and his coauthors, Carey Goldberg and Dr. Zak Kohane, reflect on how generative AI is unfolding in real-world healthcare, drawing on earlier guest conversations to examine what’s working, what’s not, and what questions still remain.
Healthcare experts Laura Adams, Vardit Ravitsky, and Dr. Roxana Daneshjou discuss responsible AI implementation in medicine, examining governance approaches, shifting patient-provider relationships, and the identification of bias to ensure equitable deployment.
Evangelist for patient empowerment Dave deBronkart and Manatt Heath’s Christina Farr discuss how generative AI is redefining healthcare by empowering patients, challenging traditional care models, and creating new opportunities for innovation and collaboration.
Microsoft’s Dr. Matthew Lungren and Epic’s Seth Hain discuss the challenges and opportunities of leveraging generative AI for enhanced patient care and improved clinical documentation and recordkeeping at scale—plus what’s next for the technology in the field.
UC San Diego Health’s Dr. Christopher Longhurst and UC San Francisco Health’s Dr. Sara Murray explore how generative AI is changing patient care, clinical workflows, and decision-making and how they envision the technology impacting the future of healthcare.
Host Peter Lee, Microsoft Research president, discusses the motivation behind the new series and the GPT-4 encounter that helped him view the tech not only as a potential tool for improving healthcare but a chance to reexamine what it means to care for people.